Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors

FEBS Letters

Volumn 581, Issue 28, 2007, Pages 5454-5458

  Lee, Cheng Chung ^a,b,c   Kuo, Chih Jung ^b,c   Hsu, Min Feng ^b,c   Liang, Po Huang ^c,d,e   Fang, Jim Min ^d,e   Shie, Jiun Jie ^d   Wang, Andrew H J ^a,b,c,d,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Metal ion; Protease inhibitor; SARS

Indexed keywords

MERCURY; PROTEINASE INHIBITOR; ZINC;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CRYSTALLOGRAPHY; GEOMETRY; NONHUMAN; PRIORITY JOURNAL; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

CYSTEINE ENDOPEPTIDASES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEASE INHIBITORS; PROTEIN BINDING; SARS VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL PROTEINS;

CORONAVIRUS; SARS CORONAVIRUS;

EID: 36048960819     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.10.048     Document Type: Article

References (23)

1. Weiss S.R., and Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 69 (2005) 635-664
2. Hsu M.F., et al. Mechanism of the maturation process of SARS-CoV 3CL protease. J. Biol. Chem. 280 (2005) 31257-31266
3. Yang H., et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA 100 (2003) 13190-13195
4. Yang S., et al. Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. J. Med. Chem. 49 (2006) 4971-4980
5. Shao Y.M., et al. Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors. Chembiochem 8 (2007) 1654-1657
6. Hsu J.T., et al. Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV. FEBS Lett. 574 (2004) 116-120
7. Someya Y., Takeda N., and Miyamura T. Characterization of the norovirus 3C-like protease. Virus Res. 110 (2005) 91-97
8. Han Y.S., et al. Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. Biochemistry 44 (2005) 10349-10359
9. Dhanak D., et al. Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease. Bioorg. Med. Chem. Lett. 10 (2000) 2279-2282
10. Tong L., et al. A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease. Nature 383 (1996) 272-275
11. Yeung K.S., et al. Structure-activity relationship studies of a bisbenzimidazole-based, Zn(2+)-dependent inhibitor of HCV NS3 serine protease. Bioorg. Med. Chem. Lett. 11 (2001) 2355-2359
12. Kuo C.J., et al. Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate. Biochem. Biophys. Res. Commun. 318 (2004) 862-867
13. Otwinowski Z., and Minor W. In: Sweet R.M. (Ed). Processing of X-ray Diffraction Data Collected in Oscillation Mode (1997), Academic, New York 307-326
14. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50 (1994) 157-163
15. Brünger A.T., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54 (1998) 905-921
16. McRee D.E. XtalView/Xfit - a versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125 (1999) 156-165
17. Katz B.A., et al. Design of potent selective zinc-mediated serine protease inhibitors. Nature 391 (1998) 608-612
18. Christianson D.W., and Lipscomb W.N. X-ray crystallographic investigation of substrate binding to carboxypeptidase A at subzero temperature. Proc. Natl. Acad. Sci. USA 83 (1986) 7568-7572
19. Brewer G.J., et al. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy. Hepatology 31 (2000) 364-370
20. Sharquie K.E., et al. Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study. J. Dermatol. 33 (2006) 541-546
21. Sakurai H., and Adachi Y. The pharmacology of the insulinomimetic effect of zinc complexes. Biometals 18 (2005) 319-323
22. Dougherty W.G., and Semler B.L. Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol. Rev. 57 (1993) 781-822
23. Sverdlov E.D., et al. Insertion of short hepatitis virus A amino acid sequences into poliovirus antigenic determinants results in viable progeny. FEBS Lett. 257 (1989) 354-356